Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

NCT00133341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Contact Dermatitis

Interventions

DRUG: Goldnatriomthiosulphate, MDBGN, parthenolide

Sponsor

Mekos Laboratories AS